Health Care & Life Sciences » Pharmaceuticals | Merrimack Pharmaceuticals Inc.

Merrimack Pharmaceuticals Inc.

Merrimack Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.59
Market Cap
$77.52 M
Shares Outstanding
13.34 M
Public Float
11.22 M

Profile

Address
One Broadway
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.merrimackpharma.com
Updated 07/08/2019
Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J.

Financials

View All

Richard Peters
President, Chief Executive Officer & Director
Gary L. Crocker
Chairman